Although the clock genes are suppressed in melanoma, treatments of circadian rhythmicity by dexamethasone trigger the recovery of rhythmic clock and cell cycle gene expression, which result in low frequency in the S phase tumor cell and high frequency in the G1 phase. The gene discussed is CLOCK; the disease is melanoma.